Evidence map›Paper›PMID 40721574›Full record

ArticleNature communications2025

DynaTag for efficient mapping of transcription factors in low-input samples and at single-cell resolution.

Pascal Hunold, Giulia Pizzolato, Nadia Heramvand, Laura Kaiser, Giulia Barbiera, Olivia van Ray, Roman Thomas, Julie George, Martin Peifer, Robert Hänsel-Hertsch

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pascal HunoldCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital, Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-7087-5908
Giulia PizzolatoCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital, Cologne, University of Cologne, Cologne, Germany.
Nadia HeramvandCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital, Cologne, University of Cologne, Cologne, Germany.
Laura KaiserDepartment of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-3212-576X
Giulia BarbieraGenevia Technologies Oy, Tampere, Finland.
Olivia van RayCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital, Cologne, University of Cologne, Cologne, Germany.
Roman ThomasDepartment of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-9132-4876
Julie GeorgeDepartment of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-4272-3683
Martin PeiferCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital, Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-5243-5503
Robert Hänsel-HertschCenter for Molecular Medicine Cologne, Faculty of Medicine and University Hospital, Cologne, University of Cologne, Cologne, Germany. robert.haensel-hertsch@uni-koeln.de.ORCID http://orcid.org/0000-0002-2835-4471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systematic discovery of transcription factor (TF) landscapes in low-input samples and at single cell level is a major challenge in the fields of molecular biology, genetics, and epigenetics. Here, we present cleavage under Dynamic targets and Tagmentation (DynaTag), enabling robust mapping of TF-DNA interactions using a physiological salt solution during sample preparation. DynaTag uncovers occupancy alterations for 15 TFs in stem cell and cancer tissue models. We highlight changes in TF-DNA binding for NANOG, MYC, and OCT4, during stem-cell differentiation, at both bulk and single-cell resolutions. DynaTag surpasses CUT&RUN and ChIP-seq in signal-to-background ratio and resolution. Furthermore, using tumours of a small cell lung cancer model derived from a single female donor, DynaTag reveals increased chromatin occupancy of FOXA1, MYC, and the mutant p53 R248Q at enriched gene pathways (e.g. epithelial-mesenchymal transition), following chemotherapy treatment. Collectively, we believe that DynaTag represents a significant technological advancement, facilitating precise characterization of TF landscapes across diverse biological systems and complex models.

Indexed as

Single-Cell AnalysisTranscription FactorsAnimalsCell DifferentiationCell Line, TumorChromatinDNAFemaleHepatocyte Nuclear Factor 3-alphaHumansNanog Homeobox ProteinOctamer Transcription Factor-3Proto-Oncogene Proteins c-mycTumor Suppressor Protein p53ChromatinDNAFOXA1 protein, humanHepatocyte Nuclear Factor 3-alphaNanog Homeobox ProteinOctamer Transcription Factor-3POU5F1 protein, humanProto-Oncogene Proteins c-mycTranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID40721574
PMCPMC12304361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.